Treatment of Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Treatment of Neovascular Age-Related Macular Degeneration

Published:2021-08 Issue: Volume: Page:
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Moisseiev Elad^ORCID,Tsai Yi-Lin^ORCID,Herzenstein Michal

Publisher

Elsevier BV

Subject

Ophthalmology

Reference30 articles.

2. Prevalence of age-related maculopathy. The Beaver Dam Eye Study;Klein;Ophthalmology,1992

3. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis;Wong;Lancet Glob Health,2014

4. Rapid expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis;Campbell;Arch Ophthalmol,2010

5. Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration;Li;Cochrane Database Syst Rev,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cognitive bias evaluation on the choice of treatment in common retinal disorders among retina specialists in 2023;Journal Français d'Ophtalmologie;2024-06

2. Clinical Outcomes of Topical Bromfenac Combined with Intravitreal Aflibercept Injection for Exudative Age-related Macular Degeneration;Journal of the Korean Ophthalmological Society;2024-01-15

3. The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration;Pharmaceutics;2024-01-13

4. Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration;Investigative Opthalmology & Visual Science;2023-10-20

5. Course of Neovascular Age-related Macular Degeneration that Showed Limited Response to Both Ranibizumab and Aflibercept;Journal of the Korean Ophthalmological Society;2023-04-15